Skip to main content
Log in

Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis

An acceptable risk/benefit ratio

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Thirty patients with psoriasis or other nonmalignant diseases had liver biopsies done before treatment with low-dose methotrexate, 15 mg/week, and then at one-to two-year intervals as long as they continued the methotrexate. All patients were symptomaticaly improved on this regimen. The 15 patients who had normal liver biopsies at the start of the study had normal biopsies after methotrexate. Fifteen others had minor hepatic histologic abnormalities before treatment. Eleven patients had fatty infiltration. Ten showed no significant change after treatment while one had increased fat and portal fibrosis on a fourth liver biopsy done seven years after MTX was begun. This last patient, a former alcohol abuser, continued methotreaxte and showed no further worsening at 8 years. The remaining four had portal fibrosis before treatment. One patient had less fibrosis after methotrexate, two patients slightly more fibrosis, and one a marked increase in portal fibrosis. No patient developed cirrhosis or clinical liver disease. Our results suggest that in the absence of alcohol consumption, low-dose weekly methotrexate treatment rarely causes clinically significannt liver damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hersh EM, Wong VG, Henderson ES, Freirich EJ: Hepatotoxic effects of methotrexate. Cancer 19:600–606, 1966

    Google Scholar 

  2. Tobias H, Auerbach R: Hepatotoxicity of long term methotrexate therapy for psoriasis Arch Intern Med 132:391–396, 1973

    Google Scholar 

  3. Weinstein GD, Cox JW, Suringa DWR, Millard MM, Kalser M, Frost P: Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis. Arch Dermatol 102:613–618, 1970

    Google Scholar 

  4. Roenigk HH, Bergfeld WF, St. Jacques R, Owens FJ, hawk WA: Hepatotoxicity of methotrexate in the treatment of psorisis. Arch Dermatol 103:251–261, 1971

    Google Scholar 

  5. Dahl GC, Gregory MM, Scheuer PJ: Liver damage due to methotrexate in patients with psoriasis. Br Med J 1:625–630, 1971

    Google Scholar 

  6. Warin AP, Landells JW: Levene GM, Baker H: A prospective study of the effects of weekly oral methotrexate on liver biopsy. Br J Dermatol 93:321–327, 1975

    Google Scholar 

  7. Nyfors A, Poulsen H: Liver biopsies from psoriatis related to methotrexate therapy. Acta Path Microbiol Scand, Sect A 84:262–270, 1976

    Google Scholar 

  8. Zachariae H, Kragballe K, Sogaard H: Methotrexate induced liver cirrhosis. Br J Dermatol 102:407–512, 1980

    Google Scholar 

  9. Robinson J, Baughman RD, Auerbach R, Cimis RJ: Methotrexate hepatitoxicity in psoriasis. Arch Dermatol 116:413–415, 1980

    Google Scholar 

  10. Delmonte L, Jukes TH: Folic acid antagonists in cancer chemotherapy. Pharm Rev 14:91–135, 1962

    Google Scholar 

  11. Coe RO, Bull FE: Cirrhosis associated with methotrexate treatment of psoriasis. JAMA 206:1515–1520, 1968

    Google Scholar 

  12. Berlin NI: Folic acid antagonists. Effects on the cell and the patient. Ann Intern Med 59:931–956, 1963

    Google Scholar 

  13. O'Rourke RA, Eckert GE: Methotrexat-induced hepatic injury in an adult. Arch Intern Med 113:191–194, 1964

    Google Scholar 

  14. Muller SA, Farrow GM, Martalock DL: Cirrhosis caused by methotrexate in the treatment of psoriasis. Arch Dermatol 100:523–530, 1969

    Google Scholar 

  15. Epstein EG Jr, Craft JD Jr: Cirrhosis following methotrexate administration for psoriasis. Arch Dermatol 100:531–534, 1969

    Google Scholar 

  16. Berge G, Lundquist A, Rorsman H, Akerman M: Liver biopsy in psoriasis. Br J Dermatol 82:250–253, 1970

    Google Scholar 

  17. Shapiro HA, Trowbridge JO, Lee JC, Akerman M: Liver disease in psoriatics-an effect of methotrexate therapy. Arch Dermatol 110:547–551, 1974

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by NIH Research Training Grant AM 07024, Clinical Study Unit Grant RR 300054, and a Fellowship from the Jack Zomlefer Fund.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lanse, S.B., Arnold, G.L., Gowans, J.D.C. et al. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. Digest Dis Sci 30, 104–109 (1985). https://doi.org/10.1007/BF01308193

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01308193

Keywords

Navigation